Clinical Trials List
2004-09-01 - 2008-12-31
Phase III
Terminated7
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 王正儀 Division of Colorectal Surgery
- Kuan-Der Lee Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 夏和雄 Division of Hematology & Oncology
- Li-Tzong Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Tsai-Sheng Yang Division of Hematology & Oncology
- Wen-Sy Tsai Division of Colorectal Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- JIN-TUNG LIANG Division of General Surgery
- Chiun Hsu Division of Hematology & Oncology
- RUEY-LONG HONG Division of Hematology & Oncology
- 謝銘鈞 Division of Hematology & Oncology
- 林璟宏 Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
- 黃敬倫 Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- SUNG-HSIN KUO Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 王緯書 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 鍾知淵 Division of Hematology & Oncology
- Tzu-Liang Chen Division of Colorectal Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 方唯則 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
1080 participants
